RiverGlades Family Offices LLC Increases Stake in CME Group Inc. (NASDAQ:CME)

RiverGlades Family Offices LLC boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 54.5% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,700 shares of the financial services provider’s stock after acquiring an additional 600 shares during the quarter. RiverGlades Family Offices LLC’s holdings in CME Group were worth $334,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Sei Investments Co. grew its holdings in shares of CME Group by 0.4% in the second quarter. Sei Investments Co. now owns 224,090 shares of the financial services provider’s stock worth $44,057,000 after purchasing an additional 827 shares during the last quarter. Skandinaviska Enskilda Banken AB publ grew its stake in CME Group by 0.8% in the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 72,718 shares of the financial services provider’s stock worth $14,293,000 after acquiring an additional 572 shares in the last quarter. AE Wealth Management LLC purchased a new position in shares of CME Group during the second quarter worth approximately $200,000. King Luther Capital Management Corp increased its position in shares of CME Group by 3.5% during the second quarter. King Luther Capital Management Corp now owns 4,408 shares of the financial services provider’s stock worth $867,000 after acquiring an additional 148 shares during the period. Finally, Benjamin Edwards Inc. raised its stake in shares of CME Group by 5.1% during the second quarter. Benjamin Edwards Inc. now owns 2,138 shares of the financial services provider’s stock valued at $420,000 after acquiring an additional 104 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Trading Down 0.7 %

Shares of NASDAQ:CME opened at $213.16 on Friday. The business’s 50-day moving average is $207.86 and its 200 day moving average is $207.53. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $223.80. The firm has a market capitalization of $76.75 billion, a P/E ratio of 24.25, a P/E/G ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.30 earnings per share. On average, research analysts predict that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Ratings Changes

Several research analysts have commented on CME shares. Barclays raised their price objective on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Bank of America lowered shares of CME Group from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft raised their target price on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Finally, JPMorgan Chase & Co. upped their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $209.73.

Insider Activity at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.